Skip to main content
Log in

Severe arterial hypertension: a possible complication of McCune-Albright syndrome

  • Short Report
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

McCune-Albright syndrome is characterized by café-au-lait spot, multiple endocrine hyperfunction, and polyostotic fibrous dysplasia. A somatic point mutation of Gsα protein leads to an increase in the Gsα-associated hormone activity in McCune-Albright syndrome. Because cyclic adenosine 3′,5′-monophosphate stimulates the dopamine beta hydroxylase gene, an activating mutation of the Gsα protein may cause the hyperproduction of norepinephrine via dopamine. We report on a 9-year-old girl with McCune-Albright syndrome complicated by severe arterial hypertension. The urinary excretion of norepinephrine was 5- to 10-fold higher than in age-matched controls. Meta-iodobenzylguanidine scintigraphy and positron emission tomography/computed tomography (PET/CT) revealed no hot spots. These findings suggest that severe hypertension might be due to an activating mutation of Gsα protein in sympathetic ganglia. Because of the reported association of GNAS1 gene polymorphism with hypertension, our patient provides further evidence for a role of Gsα protein in hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Abbreviations

MAS:

McCune-Albright syndrome

GTPase:

Guanosine triphosphatase

cAMP:

Cyclic adenosine 3′,5′-monophosphate

LH:

Luteinizing hormone

TSH:

Thyroid-stimulating hormone

ACTH:

Adrenocorticotropin

GHRH:

Growth hormone-releasing hormone

FGF:

Fibroblast growth factor

GH:

Growth hormone

CT:

Computed tomography

MIBG:

Meta-iodobenzylguanidine

PET/CT:

Positron emission tomography/computed tomography

References

  1. Abe M, Nakura J, Yamamoto M et al (2002) Association of GNAS1 gene variant with hypertension depending on smoking status. Hypertension 40:261–265

    Article  PubMed  CAS  Google Scholar 

  2. Akintoye SO, Chebli C, Booher S et al (2002) Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. J Clin Endocrinol Metab 87:5104–5112

    Article  PubMed  CAS  Google Scholar 

  3. Bernstein D (2004) Systemic hypertension. In: Behrman RE, Kliegman RM, Jenson HB (eds) Nelson textbook of pediatrics, 17th edn, Saunders, Philadelphia, pp 1592–1598

    Google Scholar 

  4. Bonnet N, Benhamou CL, Brunet-Imbault B et al (2005) Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats. Bone 37:622–633

    Article  PubMed  CAS  Google Scholar 

  5. Colao A, Ferone D, Marzullo P et al (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102–152

    Article  PubMed  CAS  Google Scholar 

  6. De Wachter E, Vanbesien J, De Schutter I et al (2003) Rapidly developing Cushing syndrome in a 4-year-old patient during combined treatment with itraconazole and inhaled budesonide. Eur J Pediatr 162:488–489

    Article  PubMed  Google Scholar 

  7. Elefteriou F, Ahn JD, Takeda S et al (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434:514–520

    Article  PubMed  CAS  Google Scholar 

  8. Fragoso MC, Domenice S, Latronico AC et al (2003) Cushing’s syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J Clin Endocrinol Metab 88:2147–2151

    Article  PubMed  CAS  Google Scholar 

  9. Hamm HE (1998) The many faces of G protein signaling. J Biol Chem 273:669–672

    Article  PubMed  CAS  Google Scholar 

  10. Hein L (2006) Adrenoceptors and signal transduction in neurons. Cell Tissue Res 326:541–551

    Article  PubMed  CAS  Google Scholar 

  11. Jonsson KB, Zahradnik R, Larsson T et al (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656–1663

    Article  PubMed  CAS  Google Scholar 

  12. Kim KS, Ishiguro H, Tinti C et al (1994) The cAMP-dependent protein kinase regulates transcription of the dopamine beta-hydroxylase gene. J Neurosci 14:7200–7207

    PubMed  CAS  Google Scholar 

  13. Landis CA, Masters SB, Spada A et al (1989) GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340:692–696

    Article  PubMed  CAS  Google Scholar 

  14. Marini JC (2003) Do bisphosphonates make children’s bones better or brittle? N Engl J Med 349:423–426

    Article  PubMed  Google Scholar 

  15. Nakanishi N, Onozawa S, Matsumoto R et al (1995) Cyclic AMP-dependent modulation of vesicular monoamine transport in pheochromocytoma cells. J Neurochem 64:600–607

    Article  PubMed  CAS  Google Scholar 

  16. Sadler TW (1995) Autonomic nervous system. In: Sadler TW (ed). Langman’s medical embryology, 7th edn. Williams & Wilkins, Baltimore, pp 366–369

  17. Schwindinger WF, Francomano CA, Levine MA (1992) Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 89:5152–5156

    Article  PubMed  CAS  Google Scholar 

  18. Spark RF, Dickstein G, Pallotta J (1979) Complete remission of acromegaly with medical treatment. JAMA 241:573–575

    Article  PubMed  CAS  Google Scholar 

  19. Spiegel AM, Shenker A, Weinstein LS (1992) Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction. Endocr Rev 13:536–565

    PubMed  CAS  Google Scholar 

  20. Wada M, Azuma H, Bando H et al (1996) A case report of an elderly patient with acromegaly. Endocr J 43:715–718

    Article  PubMed  CAS  Google Scholar 

  21. Weinstein LS, Shenker A, Gejman PV et al (1991) Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325:1688–1695

    PubMed  CAS  Google Scholar 

  22. Yamamoto T, Imanishi Y, Kinoshita E et al (2005) The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome. J Bone Miner Metab 23:231–237

    Article  PubMed  CAS  Google Scholar 

  23. Yamamoto T, Ozono K, Kasayama S et al (1996) Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome. J Clin Invest 98:30–35

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

We thank Dr. Tsuyoshi Chihara for performing the autopsy, Dr. Tomohiko Sakai for the emergency room care, and Dr. Hisao Yoshida for treating the patient when she had viral pneumonia.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takehisa Yamamoto.

Additional information

Yasuhisa Ohata wrote the first draft of the manuscript and there have not been any honorarium, grant, or other form of payment to any of the authors in relation to this manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohata, Y., Yamamoto, T., Mori, I. et al. Severe arterial hypertension: a possible complication of McCune-Albright syndrome. Eur J Pediatr 168, 871–876 (2009). https://doi.org/10.1007/s00431-008-0848-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-008-0848-1

Keywords

Navigation